title: Ambrisentan for pulmonary arterial hypertension: long term effects on clinical status, exercise capacity and haemodynamics.
authors.forename: Michele
authors.initials: M
authors.lastname: D'Alto
authors.forename: Emanuele
authors.initials: E
authors.lastname: Romeo
authors.forename: Paola
authors.initials: P
authors.lastname: Argiento
authors.forename: Anna
authors.initials: A
authors.lastname: Correra
authors.forename: Berardo
authors.initials: B
authors.lastname: Sarubbi
authors.forename: Giancarlo
authors.initials: G
authors.lastname: Scognamiglio
authors.forename: Nicola
authors.initials: N
authors.lastname: Grimaldi
authors.forename: Maria
authors.initials: M
authors.lastname: Pignatiello
authors.forename: Raffaele
authors.initials: R
authors.lastname: Calabrò
authors.forename: Maria G
authors.initials: MG
authors.lastname: Russo
mesh_terms: D000328:Adult; D015444:Exercise / Q000502:physiology*; D005260:Female; D005500:Follow-Up Studies; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010666:Phenylpropionates / Q000494:pharmacology / Q000627:therapeutic use*; D010807:Physical Endurance / Q000187:drug effects / Q000502:physiology; D011446:Prospective Studies; D011724:Pyridazines / Q000494:pharmacology / Q000627:therapeutic use*; D013995:Time
chemical_list: D010666:Phenylpropionates; D011724:Pyridazines; C467894:ambrisentan